A

Aurobindo Pharma Ltd

Pharmaceuticals

MIDCAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 27 analysts offering recommendations for Aurobindo Pharma Ltd

82%

Buy

7%

Hold

11%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio23.0250.69
PB Ratio2.456.47
Dividend Yield0.36%0.52%

Understand what these metrics mean. 

About the company

A

Aurobindo Pharma Ltd

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions